Annual Report 2023
In 2022, the Group’s revenue rose by 14% to US$733.5 million, driven by strong ICI4 prices and higher average selling price (“ASP”), offset by the lower sales volume. The Group recorded its highest EBITDA of US$284.4 million, up 5% from 2021, while net profit decreased by 9% to US$163.6 million.
